Upcoming events

Switch to Calendar View

• WISAM Conference On-Demand

  • Start
    November 05, 2021
  •  
    (UTC-03:00)
  • End
    November 05, 2022
  •  
    (UTC-03:00)

  Register

  The WISAM 2021 Virtual Conference was held on October 15-16, 2021. If you are interested in obtaining access to the session recordings, please register! You will receive a confirmation email with instructions to access once payment is received. Please contact our office with any questions! 

  Meet the Speakers | Learning Objectives

  Overview: Evolution or revolution? 2020 felt more like a revolution. Healthcare must respond to the ever-changing needs of our society and our patients; these changes seem to be occurring with increasing speed. This conference will focus on the changes occurring in addiction medicine to aid the busy practitioners of addiction care in staying abreast of current trends and provide new and better care.

  Target Audience: This educational activity is designed for professionals across disciplines who work in addiction treatment and prevention, including physicians, PAs, nurse practitioners, nurses, pharmacists, psychologists, social workers, mental health and substance abuse counselors, recovery coaches, law enforcement and public health workers.

  Session Recordings:

  • Integrating Addiction Psychiatry into a Consultation Framework: The University of Nebraska Medical Center Experience; VaKara M. Meyer Karre, MD
  • Benzodiazepines; Matt Felgus, MD, FASAM
  • Buprenorphine Treatment in the Age of Fentanyl; Elizabeth Salisbury-Afshar, MD MPH FAAFP FACPM DFASAM, Hannah Snyder, MD, Melissa Milne, DNP, APNP, FNP-BC, CARN-AP, Charles Schauberger, MD
  • Substance Use Disorders in Adolescents: Trends, Neurobiology and Treatments; Lalit Singh, MD, MPH
  • MAT During an Epidemic and Pandemic; Beth Collier, LCSW, CSAC, ICS
  • Gender Responsive Treatment for Women with Substance Use Disorders: A Family-Centered Approach; Claudia Vankoningsveld, MA, CADC, Melissa Lemke, MA
  • Treating Methamphetamine Use Disorders; Kristin DePrey, MA, LPC, CSAC, ICS
  • Understanding Proposed Changes to DHS 75 Rules; David Galbis-Reig, MD, DFASAM
  • ASAM Criteria for the Future State; Corey Waller, MD, MS, FACEP, DFASAM

  AMA Credit Designation Statement:

  The American Society of Addiction Medicine designates this enduring material for a maximum of 9.25AMA PRA Category 1 Credit (s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  ACCME Accreditation Statement:

  This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The Wisconsin Society of Addiction Medicine (WISAM). The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

  

  Planning Committee and Faculty Disclosure Information:
  (All faculty and planning committee members had no disclosures)

  WISAM 2021 Conference Planning Committee:

  • Subhadeep Barman, MD, FASAM
  • Ritu Bhatnagar, MD
  • Nameeta Dookeran, MD, MSc, FASAM
  • Matthew Felgus, MD, FASAM
  • David Galbis-Reig, MD, DFASAM
  • Ted Hall, PharmD
  • Mary-Anne Kowol, MD
  • Alison Miller, DO
  • Elizabeth Salisbury-Afshar, MD, MPH
  • Charles Schauberger, MD, MS

  WISAM 2021 Conference Faculty:

  • Elizabeth Collier, LCSW, CSAC, ICS
  • Kristin DePrey, MA, LPC, CSAC, ICS
  • Matt Felgus, MD, DFASAM
  • David Galbis-Reig, MD, DFASAM
  • VaKara M. Meyer Karre, MD
  • Claudia Van Koningsveld, MA, CADC
  • Melissa Lemke, MA
  • Melissa Milne, DNP, APNP, FNP-BC, CARN-AP
  • Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM
  • Charles Schauberger, MD, MS
  • Lalit Singh, MD, MPH
  • Hannah Snyder, MD
  • Corey Waller, MD, MS, FACEP, DFASAM

  ASAM CME Committee Reviewer:
  Cara A. Poland, MD, MEd, DFASAM
  No disclosures

  In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

  Show details
• WISAM Open Exchange

  • When
    May 26, 2022
  •  
    7:00 PM - 8:00 PM
  • Location
    Zoom

  WISAM Open Exchange
  Thursday, May 26, 2022

  Discussion Topic: Update on Cannabis Research
  Lead: David Galbis-Reig, MD, DFASAM

  Zoom Details:

  Click Here to join Zoom Meeting

  Meeting ID: 830 2253 3355
  Passcode: 734637

  One tap mobile
  +13017158592,,83022533355# US (Washington DC)
  +13126266799,,83022533355# US (Chicago)

  Questions? Email us!

  Show details
• Buprenorphine X-Waiver Training Webinar

  • When
    June 17, 2022
  •  
    8:00 AM - 12:30 PM
  • Location
    Zoom Webinar

  Buprenorphine X-Waiver Training Webinar

  DATE: Friday, June 17, 2022
  TIME:  8:00 AM - 12:30 PM
  LOCATION: Zoom Webinar (Link provided once registered)

  PRESENTER: Alison Miller, DO

  Register Here

  After registering, you will receive a confirmation email containing information about joining the webinar.

  Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine.  This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their  Buprenorphine Waver through the American Society of Addiction Medicine. 

  

  
  

  ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.

  ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

  DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  The American Society of Addiction Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.

  Show details
• WISAM Beyond the Waiver Course

  • When
    June 23, 2022
  •  
    7:00 AM - 9:00 AM
  • Location
    Virtual

  WISAM Beyond the Waiver Course
  Thursday, June 23, 2022 | 7:00-9:00 AM (central)

  Register today to participate in the Beyond the Waiver Course, created by WISAM, in order to provide Primary Care Providers who have their X-waiver an opportunity to learn more and ask questions. Once a provider has their waiver and has started treating opioid use disorder (OUD) with buprenorphine from the office based setting, there are some common clinical challenges that arise. Because of the removal of the formal 4 hour course for waiver, it is important to provide more in-depth discussion of these concerns and how to manage them from the office-based setting. This course aims to fill that knowledge gap.

  Register Here

  Learning Objectives:

  At the end of the course, the participant will be able to:

  • Explain how to navigate the following situations in the treatment of opioid use disorder (OUD) from the office based setting:
  • Buprenorphine in the presence of fentanyl
  • Interpretation of urine drug screens in clinical practice
  • Pain management with buprenorphine
  • Alcohol and OUD
  • Mental health and OUD
  • Person wants to taper off buprenorphine

  

  AMA Credit Designation Statement:
  The American Society of Addiction Medicine designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  ACCME Accreditation Statement:
  This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine (ASAM) and the Wisconsin Society of Addiction Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

  Disclosure Information:

  • CME Committee Reviewer Disclosure Information: Noel Ilogu, MD – No relevant financial disclosures
  • Faculty and Planner Disclosure Information: Ritu Bhatnagar, MD, MPH, FASAM – No Relevant Financial Disclosures

  Show details
• WISAM Public Policy Committee Meeting

  • When
    June 28, 2022
  •  
    8:00 PM - 9:00 PM
  • Location
    Virtual

  WISAM Public Policy Committee Meeting

  Tuesday, June 28, 2022
  8:00-9:00 PM (Central)
  Public Policy Chair: Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM

  All WISAM members are welcome to join. Please email the WISAM office if you are interested in joining the WISAM PPC. You will then be provided instructions for joining the zoom meeting. 

  Show details
• WISAM Quick Start to Treatment Course

  • When
    July 11, 2022
  •  
    3:00 PM - 5:00 PM
  • Location
    Virtual

  WISAM Quick Start to Treatment of Opioid Use Disorders: Buprenorphine Focus Course
  Monday, July 11, 2022 | 3:00-5:00 PM (central)

  Register today to participate in the Quick Start to Treatment of Opioid Use Disorders: Buprenorphine Focus Course, created by WISAM, in order to provide Primary Care Providers who are interested in treating opioid use disorders the opportunity to learn more and ask questions. With waiver requirements being reduced, primary care providers may be more interested in treating OUD, but still lack knowledge of mechanism of MAT and how to implement into their office based setting. 

  Register Here

  Learning Objectives:

  At the end of the course, the participant will be able to:

  • Explain the role of medications in the treatment of opioid use disorder (OUD)
  • Describe pharmacology of buprenorphine
  • Describe use of buprenorphine in OUD treatment from office-based setting
  • Understand how to manage common concerns in the treatment of OUD
  • Consider role of buprenorphine in their practice

  

  AMA Credit Designation Statement:

  The American Society of Addiction Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  ACCME Accreditation Statement:

  This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine (ASAM) and the Wisconsin Society of Addiction Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

  Disclosure Information:

  • CME Committee Reviewer Disclosure Information: Herbert L. Malinoff, MD, FACP, DFASAM – No relevant financial disclosures
  • Faculty and Planner Disclosure Information: Ritu Bhatnagar, MD, MPH, FASAM – No Relevant Financial Disclosures; Dr. Subhadeep Barman, MD, FAPA, FASAM, FASCP – No Relevant Financial Disclosures

  Show details
• Buprenorphine X-Waiver Training Webinar

  • When
    August 12, 2022
  •  
    8:00 AM - 12:30 PM
  • Location
    Zoom Webinar

  Buprenorphine X-Waiver Training Webinar

  DATE: Friday, August 12, 2022
  TIME:  8:00 AM - 12:30 PM
  LOCATION: Zoom Webinar (Link provided once registered)

  PRESENTER: David Galbis-Reig, MD, DFASAM

  Register Here

  After registering, you will receive a confirmation email containing information about joining the webinar.

  Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine.  This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their  Buprenorphine Waver through the American Society of Addiction Medicine. 

  

  
  

  ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.

  ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

  DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  The American Society of Addiction Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.

  Show details
• WISAM 2022 Annual Conference

  • Start
    October 13, 2022
  • End
    October 14, 2022
  • Location
    Madison, WI

  
  

  SAVE THE DATE

  Mark your calendars and plan to join us for WISAM's 2022 Annual Conference. The event will be held in-person at the Pyle Center in Madison, WI on Thursday, October 13 and Friday, October 14, 2022.

  Show details
• WISAM Annual Business Meeting

  • When
    October 14, 2022
  •  
    12:30 PM - 12:45 PM
  • Location
    Madison, WI

  WISAM 2022 Annual Business Meeting

  WISAM's 2022 Annual Meeting is scheduled for Friday, October 14 from 12:30-12:45 PM during the lunch break at the WISAM Annual Conference. All members are encouraged to attend. Agenda TBA.

  Show details